The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Statin-Global Market Insights and Sales Trends 2024
Synopsis
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.
The global Statin market size is expected to reach US$ 16430 million by 2029, growing at a CAGR of 1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Statin in various end use industries. The expanding demands from the Cardiovascular Disorders, Obesity, Inflammatory Disorders and Others, are propelling Statin market. Astrovastatin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluvastatin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Statin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Statin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Statin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Statin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Statin covered in this report include AstraZeneca, Merck, Pfizer, Amgen and Aurobindo Pharma, etc.
The global Statin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
Global Statin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Statin market, Segment by Type:
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Global Statin market, by Application
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Statin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Statin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.
The global Statin market size is expected to reach US$ 16430 million by 2029, growing at a CAGR of 1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Statin in various end use industries. The expanding demands from the Cardiovascular Disorders, Obesity, Inflammatory Disorders and Others, are propelling Statin market. Astrovastatin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluvastatin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Statin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Statin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Statin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Statin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Statin covered in this report include AstraZeneca, Merck, Pfizer, Amgen and Aurobindo Pharma, etc.
The global Statin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
Global Statin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Statin market, Segment by Type:
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Global Statin market, by Application
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Statin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Statin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Statin Market Overview
1.1 Statin Product Overview
1.2 Statin Market Segment by Type
1.2.1 Astrovastatin
1.2.2 Fluvastatin
1.2.3 Lovastatin
1.2.4 Pravastatin
1.2.5 Simvastatin
1.2.6 Others
1.3 Global Statin Market Size by Type
1.3.1 Global Statin Market Size Overview by Type (2018-2029)
1.3.2 Global Statin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Statin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Statin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Statin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Statin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Statin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Statin Sales Breakdown by Type (2018-2023)
2 Global Statin Market Competition by Company
2.1 Global Top Players by Statin Sales (2018-2023)
2.2 Global Top Players by Statin Revenue (2018-2023)
2.3 Global Top Players by Statin Price (2018-2023)
2.4 Global Top Manufacturers Statin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Statin Market Competitive Situation and Trends
2.5.1 Statin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Statin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Statin as of 2022)
2.7 Date of Key Manufacturers Enter into Statin Market
2.8 Key Manufacturers Statin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Statin Status and Outlook by Region
3.1 Global Statin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Statin Historic Market Size by Region
3.2.1 Global Statin Sales in Volume by Region (2018-2023)
3.2.2 Global Statin Sales in Value by Region (2018-2023)
3.2.3 Global Statin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Statin Forecasted Market Size by Region
3.3.1 Global Statin Sales in Volume by Region (2024-2029)
3.3.2 Global Statin Sales in Value by Region (2024-2029)
3.3.3 Global Statin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Statin by Application
4.1 Statin Market Segment by Application
4.1.1 Cardiovascular Disorders
4.1.2 Obesity
4.1.3 Inflammatory Disorders
4.1.4 Others
4.2 Global Statin Market Size by Application
4.2.1 Global Statin Market Size Overview by Application (2018-2029)
4.2.2 Global Statin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Statin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Statin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Statin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Statin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Statin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Statin Sales Breakdown by Application (2018-2023)
5 North America Statin by Country
5.1 North America Statin Historic Market Size by Country
5.1.1 North America Statin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Statin Sales in Volume by Country (2018-2023)
5.1.3 North America Statin Sales in Value by Country (2018-2023)
5.2 North America Statin Forecasted Market Size by Country
5.2.1 North America Statin Sales in Volume by Country (2024-2029)
5.2.2 North America Statin Sales in Value by Country (2024-2029)
6 Europe Statin by Country
6.1 Europe Statin Historic Market Size by Country
6.1.1 Europe Statin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Statin Sales in Volume by Country (2018-2023)
6.1.3 Europe Statin Sales in Value by Country (2018-2023)
6.2 Europe Statin Forecasted Market Size by Country
6.2.1 Europe Statin Sales in Volume by Country (2024-2029)
6.2.2 Europe Statin Sales in Value by Country (2024-2029)
7 Asia-Pacific Statin by Region
7.1 Asia-Pacific Statin Historic Market Size by Region
7.1.1 Asia-Pacific Statin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Statin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Statin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Statin Forecasted Market Size by Region
7.2.1 Asia-Pacific Statin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Statin Sales in Value by Region (2024-2029)
8 Latin America Statin by Country
8.1 Latin America Statin Historic Market Size by Country
8.1.1 Latin America Statin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Statin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Statin Sales in Value by Country (2018-2023)
8.2 Latin America Statin Forecasted Market Size by Country
8.2.1 Latin America Statin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Statin Sales in Value by Country (2024-2029)
9 Middle East and Africa Statin by Country
9.1 Middle East and Africa Statin Historic Market Size by Country
9.1.1 Middle East and Africa Statin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Statin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Statin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Statin Forecasted Market Size by Country
9.2.1 Middle East and Africa Statin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Statin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Statin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Statin Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Statin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Statin Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Statin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Statin Products Offered
10.3.5 Pfizer Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Statin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amgen Statin Products Offered
10.4.5 Amgen Recent Development
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Company Information
10.5.2 Aurobindo Pharma Introduction and Business Overview
10.5.3 Aurobindo Pharma Statin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Aurobindo Pharma Statin Products Offered
10.5.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Statin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Statin Industrial Chain Analysis
11.4 Statin Market Dynamics
11.4.1 Statin Industry Trends
11.4.2 Statin Market Drivers
11.4.3 Statin Market Challenges
11.4.4 Statin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Statin Distributors
12.3 Statin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
